Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)
Saudi Arabia · Delayed Price · Currency is SAR 157.90
+1.90 (1.22%)
Jun 11, 2026, 3:12 PM AST
TADAWUL:4015 Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, TADAWUL:4015 stock has a consensus rating of "Hold" and an average price target of SAR 164.24. The average 1-year stock price forecast is 4.02% higher than the current stock price, while the lowest is SAR 160.00 (+1.33%) and the highest is SAR 172.00 (+8.93%).
Price Target: SAR 164.24 (+4.02%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for TADAWUL:4015 stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 4 | 4 | 2 | 1 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 3 | 3 | 3 | 3 |
Financial Forecast
Revenue This Year
1.62B
from 1.50B
Increased by 7.75%
Revenue Next Year
1.87B
from 1.62B
Increased by 15.71%
EPS This Year
6.92
EPS Next Year
8.28
from 6.92
Increased by 19.65%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.6B | ||
| Avg | 1.6B | ||
| Low | 1.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.8% | ||
| Avg | 7.8% | ||
| Low | 7.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.92 | ||
| Avg | 6.92 | ||
| Low | 6.92 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 36.0% | ||
| Avg | 36.0% | ||
| Low | 36.0% |